RxDoctor Payments Data

Joseph Forrester, MD

Critical Care Medicine · Greenwood Village, CONPI 1316951296

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $891 of the $1,379 with a category attached, or 64.6%. 9 manufacturers reported payments, led by Johnson & Johnson at 38.6% of the total. Reporting peaked in 2021 at $773 and has fallen 81.3% since, to $145 in 2023.

$1,379in general payments, 2019–2025

Across 19 payments — averaging $72.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$532
  • Inspire Medical Systems, Inc.$276
  • Abiomed$270
  • ZOLL Respicardia, Inc.$149
  • GSK$53
  • Sanofi$40
  • plus $59 from 3 others

What the payments were for

  • Travel & lodging$48835%
  • Food & beverage$89165%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,379 in reported general payments places this provider in the 70th percentile of 141 critical care medicine providers in Colorado.

See all critical care medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$40,307
Medicare patients
171
Services billed
458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$12,875
Spiriva RespimatTiotropium Bromide13$9,932
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$7,825
Advair HfaFluticasone Propion/Salmeterol12$5,333
SymbicortBudesonide/Formoterol Fumarate12$4,943
Albuterol Sulfate HfaAlbuterol Sulfate14$560
Prednisone22$157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSpiriva Respimat$29$9,93213 claims
GSKAnoro Ellipta$53$7,82515 claims
AstraZenecaSymbicort$12$4,94312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 141 critical care medicine providers in Colorado.

Other critical care medicine in Greenwood Village

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →